0001209191-20-058450.txt : 20201116 0001209191-20-058450.hdr.sgml : 20201116 20201116160143 ACCESSION NUMBER: 0001209191-20-058450 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201113 FILED AS OF DATE: 20201116 DATE AS OF CHANGE: 20201116 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Maloberti Renaud Bertrand CENTRAL INDEX KEY: 0001744025 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37969 FILM NUMBER: 201316587 MAIL ADDRESS: STREET 1: 10 ACORN WAY CITY: GEORGETOWN STATE: MA ZIP: 01833 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ENDRA Life Sciences Inc. CENTRAL INDEX KEY: 0001681682 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 260579295 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3600 GREEN COURT STREET 2: SUITE 350 CITY: ANN ARBOR STATE: MI ZIP: 48105 BUSINESS PHONE: 734-335-0468 MAIL ADDRESS: STREET 1: 3600 GREEN COURT STREET 2: SUITE 350 CITY: ANN ARBOR STATE: MI ZIP: 48105 FORMER COMPANY: FORMER CONFORMED NAME: Endra Inc. DATE OF NAME CHANGE: 20160805 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-11-13 0 0001681682 ENDRA Life Sciences Inc. NDRA 0001744025 Maloberti Renaud Bertrand C/O ENDRA LIFE SCIENCES INC. 3600 GREEN COURT, SUITE 350 ANN ARBOR MI 48105 0 1 0 0 Chief Commercial Officer Common Stock 2020-11-13 4 S 0 10000 0.81 D 66580 D Represents shares sold pursuant to a 10b5-1 trading plan to pay withholding taxes due in connection with the vesting of certain restricted stock units. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.82 to $0.83, inclusive. The reporting person undertakes to provide to ENDRA Life Sciences Inc., any security holder of ENDRA Life Sciences Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote. Includes unvested restricted stock units. /s/ Renaud B. Maloberti by Mark R. Busch, attorney-in-fact 2020-11-16